Detalhe da pesquisa
1.
Synthesis, molecular docking studies of formononetin derivatives as potent Bax agonists for anticancer activity.
Nat Prod Res
; : 1-15, 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921074